10x Science has raised a $4.8 million seed round to help pharmaceutical researchers evaluate the growing flood of AI-generated potential drug molecules.

Novo Nordisk will integrate OpenAI's AI across its operations to accelerate drug development, including obesity and diabetes treatments.